Weed Stocks Up In Smoke – Canopy Growth Canada Equities Healthcare by Matt - November 17, 2016February 21, 20180 When Justin Trudeau became Prime Minister, an acquaintance decided to purchase a reasonably large amount of marijuana stocks (whether they were on the Venture Exchange or Over the Counter, we do not know). The gentleman had a 700% return on investment and used the proceeds for a down payment on a home. Good for him. Marijuana stocks have been on a tear lately and have become a trader’s favourite. Volume is high and volatility is huge. The Marijuana plebiscites on Super Tuesday saw public approval for the legalisation of recreational cannabis use across a few States, fueling sentiment. The pseudo-medicinal health industry has vastly improved their marketing efforts, with professional investor relations materials and the absence of marijuana leaves as a logo. A couple of stocks have stood out in particular. Canopy Growth Corp (TSE: CGC) and Aphria (TSE: APH), which have climbed precipitously before whipsawing today. Aphria now has Arlene Dickinson of Dragon’s Den fame on their Board of Directors, which provided a healthy boost to valuation over the last little while. From a fundamental perspective, the valuation is off. A quick sizing exercise (check out more sizing questions and brain teasers in our interview section), we assume 25% of the Canadian population tokes up fairly regularly (8 million people), and including casuals, at a cost of $5 a day (1 spliff; these figures have not been vetted because we unreservedly disapprove of illicit substances). We are assuming constant market penetration as a percentage of the population, so we expect real income to increase at the rate of population growth. Accordingly, we calculate 365*8 million*$5 = $15 billion dollars. As a sanity check, our halfhearted Google search yielded estimates for the recreational cannabis market from $2.5 billion to $23 billion. The Google valuation range affirms that we are very smart. Earlier today, Canopy Growth Corp was worth over $2 billion with $28 million in annualised last quarter revenues and very negative EBITDA and net income (source: FactSet, we are not diving into their financials). As far as their assets go, FactSet states they have a warehouse. Accordingly, we have difficulties reconciling the valuation gap, especially because that $15 billion in revenue will come with costs in a competitive market and low barriers to entry. Additionally, we expect marijuana as a business to benefit from economies of scale, so a Loblaws or Walmart could easily purchase a gigantic greenhouse and price out all of these fledglings. However, as with 3D Printing and Bitcoin, there may be room for this bubble to grow before it pops. Currently, the momentum is very much on the positive side (we have not looked at the technicals, nor are we experts) while there remains to be a number of psychological catalysts within the next five months. The first is an expectation that there will be guidance from the Federal Government before the end of November (all hearsay). The second is 4/20, which may not actually come with any legislative action, but retail sentiment may carry the wave a little further due to the cultural significance of the date. Ultimately our conclusion is that we do not give actual stock advice on this site, especially pertaining to speculative individual securities. Our other conclusion is no. If our readership endeavours to play this market nonetheless, we recommend a stop-loss. Often, a superior investment idea appears when testing an alternative thesis. The new idea is this. Start a marijuana company and get it publicly listed. Editor’s Note: We think some of these tickers are quite droll/gauche – of note THC – THC Biomed Intl Ltd, EAT – Nutritional High International, TBP – Tetra Bio-Pharma, SUN – Wildflower Marijuana Inc. (with a market cap of $11 million… stay away) – This post is not an endorsement of cannabis, regardless of its legal status over the next 12-24 months. We categorically repudiate mood-altering substances. Related Readings for Weed Stocks EquitiesEquities, Shares and Stocks | 股本和股票 · Greater Good Utilitarian Principles in China and Investing Implications · The Sky Is Falling · Responsible Investing Primer · Should I Buy Weed Stocks? · Investing in Stocks Today with the Trump Backdrop · Block Trades/Block Sales · Purchasing a Company via Cash or Stock · Macro Brief for Interviews on Equities · A Conversation About Risk and Reward · Interview with: Equity Research Associate · Weed Stocks Up In Smoke – Canopy Growth · President Trump · HealthcareFunding the Cannabis Industry · Canadian Cannabis Industry Overview · Should I Buy Weed Stocks? · Weed Stocks Up In Smoke – Canopy Growth · Share on Facebook Share Share on TwitterTweet Share on LinkedIn Share Print Print